Investigating how certain immune system boosters work together to improve vaccine effectiveness.
Mechanistic evaluation of mast cell agonists combined with TLR, NOD and STING agonists.
This study is looking at how to make vaccines work better by mixing different immune boosters, and it's for anyone interested in improving vaccine effectiveness for stronger and longer-lasting protection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11000790 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of subunit vaccines by combining different immune system boosters, known as adjuvants. It specifically examines the role of mast cell agonists in conjunction with other immune stimulators like TLR, NOD-2, and STING agonists. By studying these combinations in both mice and human cells, the research aims to identify synergistic pairs that can elicit stronger immune responses. This could lead to vaccines that provide better protection and longer-lasting immunity.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults or individuals with weakened immune systems who may benefit from improved vaccine responses.
Not a fit: Patients who are not immunocompromised or those who do not require vaccination may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against diseases, especially for vulnerable populations.
How similar studies have performed: Previous research has shown that combining different adjuvants can enhance vaccine efficacy, suggesting that this approach has potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ainslie, Kristy M — Univ of North Carolina Chapel Hill
- Study coordinator: Ainslie, Kristy M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.